Drugmakers Biogen and AbbVie said they are pulling their new multiple-sclerosis treatment Zinbryta from all global markets after several European patients suffered serious inflammatory brain disorders.
Source:: Biogen and Abbvie Take Multiple Sclerosis Drug Off Market